Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019

Ariel Israel, Matitiahu Berkovitch, Eugene Merzon, Avivit Golan-Cohen, Ilan Green, Eytan Ruppin, Shlomo Vinker, Eli Magen

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


In this cohort study conducted in a national healthcare organization in Israel, we found that individuals with glucose-6-phosphate dehydrogenase deficiency had an increased risk of coronavirus disease 2019 (COVID-19) infection and severity, with higher rates of hospitalization and diagnosed long COVID.

Original languageEnglish
Pages (from-to)972-975
Number of pages4
JournalClinical Infectious Diseases
Issue number7
StatePublished - 1 Oct 2023
Externally publishedYes


  • COVID-19
  • G6PD deficiency
  • glucose-6-phosphate dehydrogenase

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019'. Together they form a unique fingerprint.

Cite this